BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22800606)

  • 1. Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS.
    Cappello V; Vezzoli E; Righi M; Fossati M; Mariotti R; Crespi A; Patruno M; Bentivoglio M; Pietrini G; Francolini M
    Mol Cell Neurosci; 2012 Aug; 51(1-2):12-21. PubMed ID: 22800606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis.
    Galbiati M; Onesto E; Zito A; Crippa V; Rusmini P; Mariotti R; Bentivoglio M; Bendotti C; Poletti A
    Pharmacol Res; 2012 Feb; 65(2):221-30. PubMed ID: 22178654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
    Gould TW; Buss RR; Vinsant S; Prevette D; Sun W; Knudson CM; Milligan CE; Oppenheim RW
    J Neurosci; 2006 Aug; 26(34):8774-86. PubMed ID: 16928866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
    Tremblay E; Martineau É; Robitaille R
    J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
    Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
    Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
    Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
    PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of physical exercise and anabolic steroid treatment on spinal motoneurons and surrounding glia of wild-type and ALS mice.
    Kassa RM; Bonafede R; Boschi F; Bentivoglio M; Mariotti R
    Brain Res; 2017 Feb; 1657():269-278. PubMed ID: 28048973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic vesicle pools at diaphragm neuromuscular junctions vary with motoneuron soma, not axon terminal, inactivity.
    Mantilla CB; Rowley KL; Zhan WZ; Fahim MA; Sieck GC
    Neuroscience; 2007 Apr; 146(1):178-89. PubMed ID: 17346898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1
    Sengupta-Ghosh A; Dominguez SL; Xie L; Barck KH; Jiang Z; Earr T; Imperio J; Phu L; Budayeva HG; Kirkpatrick DS; Cai H; Eastham-Anderson J; Ngu H; Foreman O; Hedehus M; Reichelt M; Hotzel I; Shang Y; Carano RAD; Ayalon G; Easton A
    Neurobiol Dis; 2019 Apr; 124():340-352. PubMed ID: 30528255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vcp overexpression and leucine supplementation extend lifespan and ameliorate neuromuscular junction phenotypes of a SOD1G93A-ALS mouse model.
    Huang TN; Shih YT; Yen TL; Hsueh YP
    Hum Mol Genet; 2024 May; 33(11):935-944. PubMed ID: 38382647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
    Martineau É; Arbour D; Vallée J; Robitaille R
    J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Fabbrizio P; Apolloni S; Bianchi A; Salvatori I; Valle C; Lanzuolo C; Bendotti C; Nardo G; Volonté C
    Brain Pathol; 2020 Mar; 30(2):272-282. PubMed ID: 31376190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
    Moloney EB; Hobo B; De Winter F; Verhaagen J
    PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
    Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis.
    Rizzuto E; Pisu S; Musarò A; Del Prete Z
    Ann Biomed Eng; 2015 Sep; 43(9):2196-206. PubMed ID: 25631208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.
    Arbour D; Tremblay E; Martineau É; Julien JP; Robitaille R
    J Neurosci; 2015 Jan; 35(2):688-706. PubMed ID: 25589763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.